LSM10: A Potential Drug Target for Various Diseases (G84967)

Target Name: LSM10

NCBI ID: G84967

LSM10

LSM10: A Potential Drug Target for Various Diseases

LSM10 (MSTP074) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and lungs. It is a member of the LSM family of proteins, which are known for their role in intracellular signaling. LSM10 has been shown to play a role in the regulation of cell adhesion, and is potential drug target for various diseases.

One of the unique features of LSM10 is its ability to interact with several different signaling pathways. LSM10 has been shown to interact with the TGF-β pathway, which is involved in the regulation of cell growth and differentiation. This interaction between LSM10 and TGF-β suggests that LSM10 may be a useful target for drugs that are designed to modulate TGF-β signaling.

Another potential mechanism by which LSM10 may be involved in disease is its role in the regulation of cell death. LSM10 has been shown to play a role in the regulation of cell death, particularly in the context of neurodegenerative diseases. This suggests that LSM10 may be a useful target for drugs that are designed to prevent or reverse neurodegeneration.

In addition to its potential role in neurodegenerative diseases, LSM10 may also be a useful target for other conditions. For example, LSM10 has been shown to play a role in the regulation of cell adhesion in various tissues, including the skin and the gut. This suggests that LSM10 may be a useful target for drugs that are designed to modulate cell adhesion in these tissues.

Overall, LSM10 is a protein that has the potential to be a drug target for a variety of diseases. Its ability to interact with multiple signaling pathways, including TGF-β, suggests that LSM10 may be a versatile target for small molecules that can modulate its function. Further research is needed to fully understand the role of LSM10 in disease and to develop effective treatments.

Protein Name: LSM10, U7 Small Nuclear RNA Associated

Functions: Appears to function in the U7 snRNP complex that is involved in histone 3'-end processing. Increases U7 snRNA levels but not histone 3'-end pre-mRNA processing activity, when overexpressed. Required for cell cycle progression from G1 to S phases. Binds specifically to U7 snRNA. Binds to the downstream cleavage product (DCP) of histone pre-mRNA in a U7 snRNP dependent manner

The "LSM10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LSM10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets